Evaluating the optimal duration of medication treatment for opioid use disorder

Documents similaires

• Medications for opioid use disorder: Predictors of early discontinuation and reduction of overdose risk in US military veterans by medication type
  par: Corey J. Hayes, et autres
  Publié: (2024)
• Impact of study design decisions on identification of treatment initiators of medications for opioid use disorder
  par: Payel J. Roy, et autres
  Publié: (2025)
• Patient outcomes following buprenorphine treatment for opioid use disorder: A retrospective analysis of the influence of patient‐ and prescriber‐level characteristics in Massachusetts, USA
  par: Gary J. Young, et autres
  Publié: (2024)
• Empirically contrasting urine drug screening‐based opioid use disorder treatment outcome definitions
  par: Laura Brandt, et autres
  Publié: (2024)
• Case Series: Magnitude and duration of fentanyl and xylazine detection in the urine of persons with opioid use disorder
  par: Helen E. Bird, et autres
  Publié: (2025)